Co-morbidity and Refractory Asthma - UK Severe Asthma Registry
Launched by QUEEN'S UNIVERSITY, BELFAST · Sep 11, 2020
Trial Information
Current as of June 04, 2025
Recruiting
Keywords
ClinConnect Summary
The UK Severe Asthma Registry is a study that collects information about patients with severe asthma to help doctors better understand the condition and improve treatment options. Since 2007, this registry has been gathering data from patients who attend specialized asthma clinics across the UK. The information is kept private and secure, ensuring that no one can be identified. It is used to find out which treatments work best, identify different types of severe asthma, and help plan better services for patients in the future.
To participate, you need to be referred to a severe asthma clinic because your asthma is not well-controlled. There are no specific exclusions, so if you fit this description, you may be eligible to join. If you decide to participate, your local clinic team will keep your information updated, and you can choose to withdraw at any time. The data is managed by Queen's University Belfast and a trusted clinical services company. Remember, your participation is completely voluntary, and your privacy is a top priority.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Referral to a specialist severe asthma clinic in the UK due to inadequate asthma control
- • Exclusion Criteria: None
About Queen's University, Belfast
Queen's University Belfast is a prestigious research institution located in Northern Ireland, renowned for its commitment to advancing knowledge and improving health outcomes through innovative clinical research. The university actively engages in a diverse range of clinical trials, focusing on translational medicine and interdisciplinary collaboration to address pressing health challenges. With a strong emphasis on ethical standards and patient safety, Queen's University Belfast leverages its state-of-the-art facilities and a team of experienced researchers to contribute to the development of new therapies and enhance the understanding of various medical conditions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Belfast, , United Kingdom
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials